Protalix BioTherapeutics, Inc. (PLX) Operating Margin % [USD] 2011 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2011 to 2024.
  • Protalix BioTherapeutics, Inc. Operating Margin for the quarter ending March 31, 2024 was 13.5 %.
  • Protalix BioTherapeutics, Inc. annual Operating Margin for 2023 was 16 %.
  • Protalix BioTherapeutics, Inc. annual Operating Margin for 2022 was -27.3 %, a 48.8% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Operating Margin for 2021 was -53.4 %, a 1338% decline from 2020.
Operating Margin, Quarterly (% [USD])
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 13.5 +46.6 Jan 1, 2024 Mar 31, 2024
Q4 2023 16 +43.3 Oct 1, 2023 Dec 31, 2023
Q3 2023 21.3 +55.5 Jul 1, 2023 Sep 30, 2023
Q2 2023 18.3 +51.3 Apr 1, 2023 Jun 30, 2023
Q1 2023 -33.1 +10.1 +23.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -27.3 +26 +48.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -34.1 -9.93 -41.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -33 -6.72 -25.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -43.2 -32.4 -299% Jan 1, 2022 Mar 31, 2022
Q4 2021 -53.4 -57.7 -1338% Oct 1, 2021 Dec 31, 2021
Q3 2021 -24.2 -27.6 -814% Jul 1, 2021 Sep 30, 2021
Q2 2021 -26.3 -31.1 -646% Apr 1, 2021 Jun 30, 2021
Q1 2021 -10.8 -10.1 -1356% Jan 1, 2021 Mar 31, 2021
Q4 2020 4.31 +23.9 Oct 1, 2020 Dec 31, 2020
Q3 2020 3.39 +29.3 Jul 1, 2020 Sep 30, 2020
Q2 2020 4.81 +42.1 Apr 1, 2020 Jun 30, 2020
Q1 2020 -0.74 +48.3 +98.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -19.6 +36.8 +65.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -25.9 +193 +88.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -37.3 +122 +76.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -49.1 +97.4 +66.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -56.4 +107 +65.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -219 -40.3 -22.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -159 +44.4 +21.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -146 +131 +47.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -164 +197 +54.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -179 +273 +60.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -203 +603 +74.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -278 +503 +64.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -361 +182 +33.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -452 -1.18 K -162% Jul 1, 2016 Sep 30, 2016
Q2 2016 -806 -1.88 K -175% Apr 1, 2016 Jun 30, 2016
Q1 2016 -780 -2.64 K -142% Jan 1, 2016 Mar 31, 2016
Q4 2015 -542 +268 +33.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 727 +1.76 K Jul 1, 2015 Sep 30, 2015
Q2 2015 1.07 K +2.13 K Apr 1, 2015 Jun 30, 2015
Q1 2015 1.86 K +3.01 K Jan 1, 2015 Mar 31, 2015
Q4 2014 -811 Oct 1, 2014 Dec 31, 2014
Q3 2014 -1.04 K -743 -254% Jul 1, 2014 Sep 30, 2014
Q2 2014 -1.05 K -802 -318% Apr 1, 2014 Jun 30, 2014
Q1 2014 -1.15 K -1.12 K -3688% Jan 1, 2014 Mar 31, 2014
Q3 2013 -292 -262 -870% Jul 1, 2013 Sep 30, 2013
Q2 2013 -252 -210 -500% Apr 1, 2013 Jun 30, 2013
Q1 2013 -30.5 +432 +93.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 -34.9 +401 +92% Oct 1, 2012 Dec 31, 2012
Q3 2012 -30.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -42 Apr 1, 2012 Jun 30, 2012
Q1 2012 -463 Jan 1, 2012 Mar 31, 2012
Q4 2011 -436 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.